
Nemaura Medical NMRD
Quarterly report 2023-Q4
added 02-12-2024
Nemaura Medical Operating Expenses 2011-2026 | NMRD
Annual Operating Expenses Nemaura Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.12 M | 7.73 M | 4.59 M | 4.78 M | 4.48 M | 1.91 M | 1.55 M | 1.54 M | 1.32 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.12 M | 1.32 M | 4 M |
Quarterly Operating Expenses Nemaura Medical
| 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.54 M | 2.05 M | 2.06 M | - | 1.62 M | 1.63 M | 1.6 M | - | 1.8 M | 5.14 M | 3.34 M | - | 1.07 M | 1.07 M | 2.14 M | 911 K | 1.06 M | 1.06 M | 1.12 M | 1.26 M | 933 K | 933 K | 1.15 M | - | 476 K | 448 K | 417 K | - | 375 K | 1.19 M | 817 K | - | 329 K | 1.12 M | 793 K | - | 159 K | 784 K | 625 K | - | 340 K | 424 K | 83.9 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.14 M | 83.9 K | 1.2 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.28 | - | $ 123 M | ||
|
Electromed
ELMD
|
40.3 M | $ 25.74 | - | $ 218 M | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Globus Medical
GMED
|
547 M | $ 90.74 | - | $ 12.3 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.08 | - | $ 1.26 M | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 13.38 | - | $ 1.81 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Pulmonx Corporation
LUNG
|
121 M | $ 1.23 | - | $ 50 M | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Orthofix Medical
OFIX
|
344 M | $ 11.91 | - | $ 472 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Insulet Corporation
PODD
|
531 M | $ 182.87 | - | $ 12.9 B | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.6 | -1.96 % | $ 37.3 M | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.15 | - | $ 5.96 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.08 | - | $ 314 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
Stryker Corporation
SYK
|
11.2 B | $ 321.43 | -0.02 % | $ 123 B | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Tactile Systems Technology
TCMD
|
221 M | $ 23.57 | - | $ 539 M | ||
|
TELA Bio
TELA
|
88.1 M | $ 0.78 | - | $ 36.6 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
TransMedics Group
TMDX
|
254 M | $ 101.26 | - | $ 3.44 B | ||
|
Tandem Diabetes Care
TNDM
|
159 M | $ 18.63 | - | $ 1.27 B | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Varex Imaging Corporation
VREX
|
318 M | $ 12.07 | - | $ 500 M | ||
|
Butterfly Network
BFLY
|
123 M | $ 5.16 | - | $ 1.09 B | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Vivos Therapeutics
VVOS
|
30.4 M | $ 0.85 | - | $ 8.73 M | ||
|
Beyond Air
XAIR
|
42.9 M | $ 0.51 | - | $ 34.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.14 | - | $ 355 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 10.55 | - | $ 378 M | ||
|
Xtant Medical Holdings
XTNT
|
77 M | $ 0.55 | -1.78 % | $ 76.7 M | ||
|
Zimmer Biomet Holdings
ZBH
|
4.46 B | $ 82.8 | - | $ 16.8 B | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.04 | - | $ 17.6 M | ||
|
CONMED Corporation
CNMD
|
648 M | $ 36.79 | - | $ 1.14 B |